|
Jul 30
|
Infectious Disease Treatment Market Report 2025-2030 | Long-acting Injectables, Self-testing Kits, and Combination Therapies Fueling Growth
|
|
Jul 30
|
Eli Lilly eyes SoC status as Jaypirca proves superior to Imbruvica in CLL/SLL
|
|
Jul 30
|
[Latest] Global Lenacapavir Injection Market Size/Share Worth USD 5.68 Billion by 2034 at a 5.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
|
|
Jul 29
|
BMO says WSJ report on RFK potential headwind for Gilead
|
|
Jul 28
|
Gilead Sciences (GILD) Stock Dips While Market Gains: Key Facts
|
|
Jul 28
|
Why Gilead Sciences Stock Slipped Today
|
|
Jul 28
|
Biotech stocks dip as Trump administration mulls patent fee overhaul
|
|
Jul 28
|
Gilead Sciences stock falls amid reports of preventive health panel dismissal
|
|
Jul 28
|
Gilead wins positive European approval opinion for twice-yearly HIV injection
|
|
Jul 28
|
HCSA Community Services and Tan Tock Seng Hospital Sign MOU to Hepatitis C Elimination in Singapore
|
|
Jul 28
|
Citi Maintains a Buy Rating on Gilead Sciences (GILD)
|
|
Jul 28
|
TD Cowen Remains Bullish on Gilead Sciences (GILD)
|
|
Jul 25
|
Why Gilead Sciences (GILD) Stock Is Up Today
|
|
Jul 25
|
Why Gilead Sciences Stock Just Popped
|
|
Jul 25
|
Here's Why Gilead Sciences (GILD) is a Strong Value Stock
|
|
Jul 25
|
Gilead Receives Positive CHMP Opinions Under Accelerated Review From European Medicines Agency for Twice-Yearly Lenacapavir for HIV Prevention
|
|
Jul 25
|
Assembly Bio’s (ASMB) HBV Drug Shows Strong Efficacy in Phase 1b Trial
|
|
Jul 24
|
Gilead Sciences to Release Second Quarter 2025 Financial Results on Thursday, August 7, 2025
|
|
Jul 24
|
CAR T-Cell Therapy Market Trends and Forecasts, 2021-2024 & 2025-2033 | Focus on Yescarta, Tecartus, Kymriah, Breyanzi, Abecma, Carvykti, and Carteyva
|
|
Jul 23
|
Gilead Sciences, Omnicom Group, and QuinStreet Shares Skyrocket, What You Need To Know
|